You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
沃森生物(300142.SZ):玉溪沃森擬向銀行申請綜合授信及流動資金貸款合計10億元
格隆匯 07-28 21:43

格隆匯7月28日丨沃森生物(300142.SZ)公佈,2021年度,隨着玉溪沃森13價肺炎球菌多糖結合疫苗在全國准入銷售作的深入推進,玉溪沃森疫苗產品生產、銷售規模擴大,致疫苗產品生產、銷售業務資金支出增加;同時,玉溪沃森新增疫苗產業化建設投入及產品的研發、生產備料投入玉溪沃森階段性資金需求量較大根據玉溪沃森業務發展需要,為保證項目研發及生產經營資金需求拓寬融資渠道,玉溪沃森擬分別向農業銀行交通銀行、建設銀行申請綜合授信及流動資金貸款人民幣6億元、1億元、3億元,農業銀行交通銀行授信期限為1年,建設銀行授信期限為2年,貸款期限均為1年,用途為玉溪沃森購買原材料、耗材,支付研發費用、推廣服務費、運輸費等日常生產經營所需的資金週轉。

上述授信及流動資金貸款為信用方式,不涉及向銀行提供擔保,不涉及以任何股權、實物、房地產及無形資產抵押、質押。

玉溪沃森此次向農業銀行交通銀行、建設銀行申請綜合授信及流動資金貸款屬於公司董事會決策權限範圍,無需提交公司股東大會審議。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account